| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/11/1999 | EP0934055A1 Clear cosmetic sticks and process for its preparation |
| 08/11/1999 | EP0934040A1 Method for treating dementia due to aids |
| 08/11/1999 | EP0933998A1 Method for the prevention of the reinfestation of warm-blooded animals by ectoparasites |
| 08/11/1999 | EP0933997A1 Methods and compositions for liver specific delivery of therapeutic molecules using recombinant aav vectors |
| 08/11/1999 | EP0933995A1 Method of treating endothelial injury |
| 08/11/1999 | EP0933993A1 Substituted cyclopentane compounds useful as neuraminidase inhibitors |
| 08/11/1999 | EP0933992A1 Methods and compositions for treating urinary incontinence using enantiomerically enriched (r)-tridihexethyl |
| 08/11/1999 | EP0827514B1 Heavy metal salts of succinic acid hemiesters with hyaluronic acid, or hyaluronic acid esters, a process for their preparation, and relative pharmaceutical compositions |
| 08/11/1999 | EP0791007B1 Antifungal sordaridin derivatives |
| 08/11/1999 | EP0789706A4 Sugar modified nucleosides and their use for synthesis of oligonucleotides |
| 08/11/1999 | EP0781282B1 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE |
| 08/11/1999 | EP0741724B1 Neuroprotective chroman compounds |
| 08/11/1999 | EP0734249B1 Novel and improved aminoglycoside formulation for aerosolization |
| 08/11/1999 | EP0699240B1 Gibbon ape leukemia virus-based retroviral vectors |
| 08/11/1999 | EP0678097B1 Novel colon- or ileum-specific steroid derivatives |
| 08/11/1999 | EP0675717B1 Use of 2-amino-6-a-propylamino-4,5,6,7-tetrahydrobenzothiazole (pramipexol) as an anti-depressant drug |
| 08/11/1999 | EP0671904B1 Antibiotic formulation and use for bacterial infections |
| 08/11/1999 | EP0670721B1 Drug for treatment and prophylaxis of bone and joint diseases |
| 08/11/1999 | EP0669127B1 Prolonged-action pharmaceutical preparation |
| 08/11/1999 | EP0666741B1 Dithiocarbamates for the treatment of atherosclerosis and other cardiovascular and inflammatory diseases |
| 08/11/1999 | EP0649431B1 17-amino substituted 4-azasteroid 5-alpha-reductase inhibitors |
| 08/11/1999 | EP0642509B1 Novel potent inducers of terminal differentiation and methods of use thereof |
| 08/11/1999 | EP0636023B1 Aminoguanidine spray drying process |
| 08/11/1999 | EP0584223B1 Novel immunosuppressive compounds |
| 08/11/1999 | EP0584185B1 Treatment of fatigue syndrome with cholinesterase inhibitors |
| 08/11/1999 | EP0580778B1 Convertible microemulsion formulations |
| 08/11/1999 | EP0566666B1 Novel glucohydrolase inhibitors useful as antidiabetic antivital and antimetastatic agents |
| 08/11/1999 | EP0524211B2 Pharmaceutical formulation |
| 08/11/1999 | EP0478545B1 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents |
| 08/11/1999 | CN1225687A Method for producing Pravastatin precursor ML-236B |
| 08/11/1999 | CN1225682A Method and compositions for regulating T cell subsets by modulating transcription facter activity |
| 08/11/1999 | CN1225654A Angiogenic inhibitory compounds |
| 08/11/1999 | CN1225639A Phosphinate based inhibitors of matrix metalloproteases |
| 08/11/1999 | CN1225637A Pyrrole triazines and pyrimidines |
| 08/11/1999 | CN1225631A Bioconjugates of manganese or iron complexes of nitrogen-contg. macrocyclic ligands effective as catalysis for dismutating superoxide |
| 08/11/1999 | CN1225630A Methanesulphonate salt of an arylpiperzine derived from tryptamine and its solvates for pharmaceutical use |
| 08/11/1999 | CN1225629A Novel pyrrole derivatives |
| 08/11/1999 | CN1225625A Alpha-amino acid amides, prepn. thereof and the therapeutic use thereof |
| 08/11/1999 | CN1225624A Inhibition of matrix metalloproteases by substituted phenethyl compounds |
| 08/11/1999 | CN1225623A Inhibition of matrix metalloproteases by acetylene contg. compounds |
| 08/11/1999 | CN1225622A Substituted oxobutyric acids as matrix metalloprotease inhibitor |
| 08/11/1999 | CN1225621A Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids |
| 08/11/1999 | CN1225620A Substituted 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors |
| 08/11/1999 | CN1225591A Membrane incorporation of texaphyrins |
| 08/11/1999 | CN1225589A Purified extract of harpagophytum procumbens and/or harpagophytum zeyheri dence, process for its prodn. and its use |
| 08/11/1999 | CN1225588A Non-aqueous colonic purgative formulations |
| 08/11/1999 | CN1225587A Compositions comprising an HIV protease inhibitor such as VX 478 and a water soluble vitamin E compound such as vitamin E-TPGS |
| 08/11/1999 | CN1225585A 抗微生物组合物 The antimicrobial composition |
| 08/11/1999 | CN1225584A Tetrahydro-beta-carboline compounds |
| 08/11/1999 | CN1225583A Beta-lactam granules free of organic solvents |
| 08/11/1999 | CN1225582A Use of carbonic anhydrase inhibitors for treating macular edema |
| 08/11/1999 | CN1225581A Alpha blockers for treating erectile dysfunction e. g. moxisylyte and/or derivatives thereof |
| 08/11/1999 | CN1225580A Potassium, sodium and tris oxaprozin salt pharmaceutical formulations |
| 08/11/1999 | CN1225579A Granulates of hexalhydropyrazine derivatives which can be administered orally |
| 08/11/1999 | CN1225568A Transdermal drug delivery matrix for coadministering estradiol and another steroid |
| 08/11/1999 | CN1225555A Teat dipping agent |
| 08/11/1999 | CN1225367A Bond partner, and use for sieving inhibitor and diagnosis and treatment of disease |
| 08/11/1999 | CN1225362A Indole derivatives |
| 08/11/1999 | CN1225361A Process for the prepn. of N, N'-subistituted ureas |
| 08/11/1999 | CN1225360A Substituted imidazolidine derivatives, their prepn., their use and pharmaceutical prepn. comprising them |
| 08/11/1999 | CN1225263A Specific anti dizziness drug, and prescription thereof |
| 08/11/1999 | CN1225262A Anti cancer drug contg. taxals alcohol |
| 08/10/1999 | US5936133 2-alkylidene-19-nor-vitamin D compounds |
| 08/10/1999 | US5936128 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents |
| 08/10/1999 | US5936123 Compounds such as 3-isopropyl-4-hydrazinobenzoic acid and its salts |
| 08/10/1999 | US5936097 Antitumor agents |
| 08/10/1999 | US5936092 Fatty acid conjugate containing a disulfide linkage; increased absorption of compounds |
| 08/10/1999 | US5936089 Dipeptides which promote release of growth hormone |
| 08/10/1999 | US5936088 Nervous system disorders |
| 08/10/1999 | US5936084 Halo-substituted bisindolemaleimide protein kinase C inhibitors |
| 08/10/1999 | US5936082 Metallocorrinoids as biologically compatible carriers of pharmacological agents |
| 08/10/1999 | US5936001 Stable buffering system; for sterilizing medical equipment |
| 08/10/1999 | US5936000 Central nervous system disorders, e.g. schizophrenia, mania; antidepressants; drug abuse; parkinson's disease, anxiolytic agents; sleep and circadian rhythm disorders; senile dementia |
| 08/10/1999 | US5935998 Use of all allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection or associated diseases |
| 08/10/1999 | US5935996 Composition for stimulating osteogenesis and preventingreduction of bone salt |
| 08/10/1999 | US5935995 Poly-, oligo- and monosaccharides of drugs, e.g. nitrogen mustard gas, quinine and dipyridamole; stability; slow release; antiarthitic agents; enzyme inhibitors |
| 08/10/1999 | US5935994 Nutritionally balanced dermal composition and method |
| 08/10/1999 | US5935989 N-linked ureas and carbamates of heterocyclic thioesters |
| 08/10/1999 | US5935988 Mixtures of 2-amino-4-methylenecyclopentanecarboxylic acid with isoleucine, alanine or proline |
| 08/10/1999 | US5935987 Transdermal delivery of 3,4-diarylchromans |
| 08/10/1999 | US5935985 Phenoxyacetic acid derivatives |
| 08/10/1999 | US5935984 Heterocyclically substituted phenylglycinolamides |
| 08/10/1999 | US5935983 For treatment of restenosis |
| 08/10/1999 | US5935982 Methods of treating retroviral infection and compounds useful therefor |
| 08/10/1999 | US5935980 Use of pyrrolidine derivatives in the treatment of alcoholism |
| 08/10/1999 | US5935976 Viricides, hiv |
| 08/10/1999 | US5935975 Agonist-antagonist combination to reduce the use of nicotine and other drugs |
| 08/10/1999 | US5935974 Diphenylmethylene piperidine derivatives |
| 08/10/1999 | US5935973 Affinity for 5-ht1a, alpha1, alpha2 and/or d2 receptors; antidepressants, anxiolytic agents, psychoses, dyskinesias, parkinson's disease, hypotensive agents, tourette's syndrome, obsessive-compulsive behaviour, panic attacks, social phobias |
| 08/10/1999 | US5935972 Benzofuran derivatives as tachykinin antagonists |
| 08/10/1999 | US5935970 Treatment of nerve system disorders, neurodegenerative diseases |
| 08/10/1999 | US5935968 Methods for treating polycystic ovary syndrome |
| 08/10/1999 | US5935967 Pharmaceutical formulations of highly lipophilic camptothecin derivatives |
| 08/10/1999 | US5935962 Administering doxazosin, a metabolite or a salt |
| 08/10/1999 | US5935960 Treatment of schizophrenia |
| 08/10/1999 | US5935957 Compounds, compositions and methods for treating influenza |
| 08/10/1999 | US5935956 Pyridazine compounds |
| 08/10/1999 | US5935955 Substituted 3,6-dibenzylidene-2,5-piperazinediones, modulators of multidrug resistance |
| 08/10/1999 | US5935954 Compounds with improved multi-drug resistance activity |
| 08/10/1999 | US5935953 Methods for controlling invertebrate pests using cocaine receptor binding ligands |